作者:Na Li、GuoJing Qu、JingNa Xue、Xiao Li、Xuan Zhao、YeHao Yan、DongFang Gao、Lu Zhang、Peng Wang、Ming Zhang、BaoXiang Zhao、JunYing Miao、ZhaoMin Lin
DOI:10.1016/j.bmc.2019.05.015
日期:2019.7
Biological activities of a series of fluorescent compounds against human lung cancer cell line A549 were investigated. The results showed that (E)-1,3,3-trimethyl-2-(4-(piperidin-1-yl) styryl)-3H-indol-1-ium iodide (8) and (E)-2-(5,5-dimethyl-3-(4-(piperazin-1-yl) styryl) cyclohex-2-en-1-ylidene) malononitrile (11) could inhibit the growth of A549 cancer cells in a dose and time-dependent manner. Furthermore, compound 8 could trigger autophagy and apoptosis, but not obviously induce necrosis under the stimulatory condition. Therefore, 8 can be used as autophagy activator to investigate the regulatory mechanism of autophagy and may offer a new candidate for the treatment of lung cancer.